PortfoliosLab logoPortfoliosLab logo
IE vs. OCUL
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

IE vs. OCUL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Ivanhoe Electric Inc (IE) and Ocular Therapeutix, Inc. (OCUL). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

IE vs. OCUL - Yearly Performance Comparison


2026 (YTD)2025202420232022
IE
Ivanhoe Electric Inc
-26.03%111.66%-25.10%-17.04%12.50%
OCUL
Ocular Therapeutix, Inc.
-30.23%42.15%91.48%58.72%-25.86%

Fundamentals

EPS

IE:

$0.00

OCUL:

-$1.38

PS Ratio

IE:

322.48

OCUL:

31.49

Total Revenue (TTM)

IE:

$3.24M

OCUL:

$51.95M

Gross Profit (TTM)

IE:

$2.12M

OCUL:

$45.25M

EBITDA (TTM)

IE:

-$37.40M

OCUL:

-$258.96M

Returns By Period

In the year-to-date period, IE achieves a -26.03% return, which is significantly higher than OCUL's -30.23% return.


IE

1D
9.75%
1M
-31.24%
YTD
-26.03%
6M
-5.82%
1Y
103.44%
3Y*
-0.91%
5Y*
10Y*

OCUL

1D
14.46%
1M
-5.26%
YTD
-30.23%
6M
-27.54%
1Y
15.55%
3Y*
17.14%
5Y*
-13.42%
10Y*
-1.51%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

IE vs. OCUL — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IE
IE Risk / Return Rank: 7878
Overall Rank
IE Sharpe Ratio Rank: 8282
Sharpe Ratio Rank
IE Sortino Ratio Rank: 7979
Sortino Ratio Rank
IE Omega Ratio Rank: 7777
Omega Ratio Rank
IE Calmar Ratio Rank: 7676
Calmar Ratio Rank
IE Martin Ratio Rank: 7777
Martin Ratio Rank

OCUL
OCUL Risk / Return Rank: 5050
Overall Rank
OCUL Sharpe Ratio Rank: 5050
Sharpe Ratio Rank
OCUL Sortino Ratio Rank: 5353
Sortino Ratio Rank
OCUL Omega Ratio Rank: 5252
Omega Ratio Rank
OCUL Calmar Ratio Rank: 4747
Calmar Ratio Rank
OCUL Martin Ratio Rank: 4848
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

IE vs. OCUL - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Ivanhoe Electric Inc (IE) and Ocular Therapeutix, Inc. (OCUL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


IEOCULDifference

Sharpe ratio

Return per unit of total volatility

1.32

0.21

+1.11

Sortino ratio

Return per unit of downside risk

2.03

0.91

+1.12

Omega ratio

Gain probability vs. loss probability

1.25

1.11

+0.14

Calmar ratio

Return relative to maximum drawdown

1.88

0.20

+1.68

Martin ratio

Return relative to average drawdown

5.00

0.52

+4.49

IE vs. OCUL - Sharpe Ratio Comparison

The current IE Sharpe Ratio is 1.32, which is higher than the OCUL Sharpe Ratio of 0.21. The chart below compares the historical Sharpe Ratios of IE and OCUL, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


IEOCULDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.32

0.21

+1.11

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.17

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

-0.02

Sharpe Ratio (All Time)

Calculated using the full available price history

0.04

-0.05

+0.08

Correlation

The correlation between IE and OCUL is 0.21, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

IE vs. OCUL - Dividend Comparison

Neither IE nor OCUL has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

IE vs. OCUL - Drawdown Comparison

The maximum IE drawdown since its inception was -71.12%, smaller than the maximum OCUL drawdown of -95.19%. Use the drawdown chart below to compare losses from any high point for IE and OCUL.


Loading graphics...

Drawdown Indicators


IEOCULDifference

Max Drawdown

Largest peak-to-trough decline

-71.12%

-95.19%

+24.07%

Max Drawdown (1Y)

Largest decline over 1 year

-45.93%

-57.29%

+11.36%

Max Drawdown (5Y)

Largest decline over 5 years

-89.14%

Max Drawdown (10Y)

Largest decline over 10 years

-90.94%

Current Drawdown

Current decline from peak

-40.66%

-80.43%

+39.77%

Average Drawdown

Average peak-to-trough decline

-31.80%

-76.58%

+44.78%

Ulcer Index

Depth and duration of drawdowns from previous peaks

17.28%

22.71%

-5.43%

Volatility

IE vs. OCUL - Volatility Comparison

Ivanhoe Electric Inc (IE) has a higher volatility of 22.04% compared to Ocular Therapeutix, Inc. (OCUL) at 19.52%. This indicates that IE's price experiences larger fluctuations and is considered to be riskier than OCUL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


IEOCULDifference

Volatility (1M)

Calculated over the trailing 1-month period

22.04%

19.52%

+2.52%

Volatility (6M)

Calculated over the trailing 6-month period

56.54%

58.02%

-1.48%

Volatility (1Y)

Calculated over the trailing 1-year period

79.52%

75.47%

+4.05%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

69.31%

78.73%

-9.42%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

69.31%

80.20%

-10.89%

Financials

IE vs. OCUL - Financials Comparison

This section allows you to compare key financial metrics between Ivanhoe Electric Inc and Ocular Therapeutix, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00M10.00M15.00MAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
896.00K
13.25M
(IE) Total Revenue
(OCUL) Total Revenue
Values in USD except per share items